文献速递白血病

急性髓系白血病的蛋白质组与磷酸化蛋白质组全景

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia.
PubMed 文献 · Blood · 2022-01-01

研究基于LAML TCGA数据集中44例代表性急性髓系白血病(AML)患者和6例健康骨髓来源对照,构建了深度覆盖的蛋白质组与磷酸化蛋白质组数据库,并经正交方法验证了蛋白质组数据揭示的若干既往未描述的AML特征,包括IDH1/2突变样本中KDM4A/B/C蛋白水平升高而mRNA无变化、NPMc突变样本中核输入蛋白与NPMc相互作用、CD180与MRC1/CD206可作为免疫治疗新靶点,以及近3万个磷酸化位点中AML相关的异常磷酸化。

要点

  • 构建了44例AML患者与6例健康骨髓对照的深度蛋白质组与磷酸化蛋白质组数据库。
  • IDH1/2突变样本中KDM4A/B/C蛋白水平升高而mRNA水平无变化,并在体外验证。
  • CD180与MRC1/CD206在多数患者AML原始细胞表达而不在健康CD34+干/祖细胞表达,经流式细胞术确认。

核心结论

  • 该公开数据库将作为进一步研究AML发病机制中蛋白质失调的基础。

研究设计与样本

  • 研究从LAML TCGA数据集中选取44例代表性AML患者和6例健康骨髓来源对照,构建深度蛋白质组与磷酸化蛋白质组数据库。

主要发现

  • IDH1/2突变样本显示2-酮戊二酸依赖性组蛋白去甲基化酶KDM4A/B/C水平升高,而相应基因的mRNA水平无变化,并在体外确认该发现。
  • NPMc突变样本中鉴定出若干核输入蛋白蛋白质丰度转录后增加,并显示它们与NPMc而非野生型NPM1相互作用。
  • CD180与MRC1/CD206在多数患者AML原始细胞上表达,而不在健康CD34+干/祖细胞上表达,并经流式细胞术确认。
  • 共检测到近30000个磷酸化位点,AML样本整体上与PTPN11、STAT3、AKT1和PRKCD特定残基的异常磷酸化相关。
  • FLT3-TKD样本与细胞质Src家族酪氨酸激酶FGR和HCK激活酪氨酸磷酸化增加及相关信号蛋白相关;PML-RARA起始的AML样本显示独特磷酸化特征;TP53突变样本显示TP53自身丝氨酸183位点大量磷酸化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We have developed a deep-scale proteome and phosphoproteome database from 44 representative acute myeloid leukemia (AML) patients from the LAML TCGA dataset and 6 healthy bone marrow-derived controls. After confirming data quality, we orthogonally validated several previously undescribed features of AML revealed by the proteomic data. We identified examples of posttranscriptionally regulated proteins both globally (ie, in all AML samples) and also in patients with recurrent AML driver mutations. For example, samples with IDH1/2 mutations displayed elevated levels of the 2-oxoglutarate-dependent histone demethylases KDM4A/B/C, despite no changes in messenger RNA levels for these genes; we confirmed this finding in vitro. In samples with NPMc mutations, we identified several nuclear importins with posttranscriptionally increased protein abundance and showed that they interact with NPMc but not wild-type NPM1. We identified 2 cell surface proteins (CD180 and MRC1/CD206) expressed on AML blasts of many patients (but not healthy CD34+ stem/progenitor cells) that could represent novel targets for immunologic therapies and confirmed these targets via flow cytometry. Finally, we detected nearly 30 000 phosphosites in these samples; globally, AML samples were associated with the abnormal phosphorylation of specific residues in PTPN11, STAT3, AKT1, and PRKCD. FLT3-TKD samples were associated with increased phosphorylation of activating tyrosines on the cytoplasmic Src-family tyrosine kinases FGR and HCK and related signaling proteins. PML-RARA-initiated AML samples displayed a unique phosphorylation signature, and TP53-mutant samples showed abundant phosphorylation of serine-183 on TP53 itself. This publicly available database will serve as a foundation for further investigations of protein dysregulation in AML pathogenesis.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Kramer MH, Zhang Q, Sprung R, et al. Proteomic and phosphoproteomic landscapes of acute myeloid leukemia. Blood. 2022. PMID: 35895896. doi:10.1182/blood.2022016033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。